All Comments by Eric M. Reiman
- Scratch Lanabecestat: This BACE Inhibitor Doesn’t Work in Symptomatic AD, Either
- Hanging in There: Another BACE Inhibitor Still Safe in Phase 2
- Liver Tox Ends Janssen BACE Program
- New Definition of Alzheimer’s Hinges on Biology, Not Symptoms
- Merck Axes Verubecestat for Prodromal AD, Researchers Say ‘Go Earlier’
- New Look at Sex and ApoE4 Puts Women at Risk Earlier than Men
- As Youth Fades, So Does the Fire of Glycolysis in the Brain
- APOE4 Subtly Alters Brain Network Activity With Age
- Field Loses Another Pioneer with Passing of Allen Roses, 73
- Dale Schenk, 59, Pioneer of Alzheimer’s Immunotherapy
- Young ApoE4 Carriers Wander Off the ‘Grid’ — Early Predictor of Alzheimer’s?
- Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.
- Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.
- Protective APP Mutation Found—Supports Amyloid Hypothesis
- Brain Aβ Patterns Linked to Brain Energy Metabolism